RecruitingCystic Fibrosis (CF)Cystic Fibrosis-related DiabetesDiabetes
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Eligible age
12+ yrs
Accepts
All genders
Locations
15 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Sponsor: Jaeb Center for Health Research
You may qualify if…
- ✓ Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative
- ✓ For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes)
- ✓ Be willing and able to adhere to the study protocol requirements
- ✓ Age ≥ 12 years at time of enrollment
- ✓ CF diagnosis based on two CF causing mutations and/or positive sweat test according to CFF diagnostic criteria
- ✓ CFRD diagnosis ≥ 5 years at time of enrollment
You may not qualify if…
- ✕ History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk to the subject
- ✕ History of transplant
- ✕ Pregnancy reported by participant at time of consent or at any point during active study participation
- ✕ Pulse Wave Velocity Exclusion Criteria:
- ✕ Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias
- ✕ Carotid or aortic valve stenosis
- ✕ Peripheral artery disease or leg artery disease
- ✕ Generalized constriction or localized spasm of muscular conduit arteries such as seen immediately after hypothermic cardiopulmonary bypass surgery or accompanying Raynaud's phenomena or intense cold.
Where it's recruiting
Alabama
Birmingham
California
Los Angeles · Palo Alto · San Diego
Colorado
Aurora
Florida
Miami
Georgia
Atlanta
Iowa
Iowa City
Louisiana
New Orleans
Massachusetts
Boston
Minnesota
Minneapolis
New Mexico
Albuquerque
New York
New York
North Carolina
Winston-Salem
Source: ClinicalTrials.gov · NCT06837181 · last updated 2026-02-10